Evidence map›Paper›PMID 38607047›Full record

ArticleCells2024

Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts.

Maria Michela Pallotta, Maddalena Di Nardo, Antonio Musio

Open access · goldAbstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maria Michela PallottaInstitute for Biomedical Technologies (ITB), National Research Council (CNR), 56124 Pisa, Italy.ORCID 0000-0001-7731-8621
Maddalena Di NardoInstitute for Biomedical Technologies (ITB), National Research Council (CNR), 56124 Pisa, Italy.ORCID 0000-0002-1481-2101
Antonio MusioInstitute for Biomedical Technologies (ITB), National Research Council (CNR), 56124 Pisa, Italy.ORCID 0000-0001-7701-6543
Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" · IT

Funding

Italian Association for Cancer Research IG23284
6 · The paper itself

Abstract

Cohesin is a highly conserved ring-shaped complex involved in topologically embracing chromatids, gene expression regulation, genome compartmentalization, and genome stability maintenance. Genomic analyses have detected mutations in the cohesin complex in a wide array of human tumors. These findings have led to increased interest in cohesin as a potential target in cancer therapy. Synthetic lethality has been suggested as an approach to exploit genetic differences in cancer cells to influence their selective killing. In this study, we show that mutations in

Indexed as

CohesinsHeterocyclic Compounds, 3-RingMaleimidesNeoplasmsCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsGlycogen Synthase Kinase 3HumansSynthetic Lethal MutationsTranscription FactorsWnt Signaling Pathway3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dioneCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsGlycogen Synthase Kinase 3Heterocyclic Compounds, 3-RingMaleimidesNIPBL protein, humanPDS5B protein, humanTranscription Factorscancerc-MYCcohesinLY2090314synthetic lethalityWNTβ-catenin

Identifiers

PMID38607047
PMCPMC11011321
OpenAlexW4393356732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.